Factors associated with alcohol and drug use during unprotected anal intercourse in the previous 12 months: n, row % (n=639)
Drunk on alcohol | Used poppers | Used stimulant or recreational/illicit drugs | Used Viagra | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Never, n (%) | Always/sometimes, n (%) | p Value | Never, n (%) | Always/sometimes, n (%) | p Value | Never, n (%) | Always/sometimes, n (%) | p Value | Never, n (%) | Always/sometimes, n (%) | p Value | |
Overall | 142 (22.2) | 497 (77.8) | 407 (63.7) | 232 (36.3) | 497 (77.8) | 142 (22.2) | 549 (85.9) | 90 (14.1) | ||||
Survey location | ||||||||||||
Edinburgh | 66 (24.3) | 206 (75.7) | 0.285 | 168 (61.8) | 104 (38.2) | 0.383 | 216 (79.4) | 56 (20.6) | 0.392 | 234 (86.0) | 38 (14.0) | 0.943 |
Glasgow | 76 (20.7) | 291 (79.3) | 239 (65.1) | 128 (34.9) | 281 (76.6) | 86 (23.4) | 315 (85.8) | 52 (14.2) | ||||
Sexual orientation | ||||||||||||
Gay | 133 (22.1) | 469 (77.9) | 0.844 | 382 (63.5) | 220 (36.5) | 0.621 | 472 (78.4) | 130 (21.6) | 0.284 | 520 (86.4) | 82 (13.6) | 0.255 |
Bisexual | 8 (23.5) | 26 (76.5) | 23 (67.6) | 11 (32.4) | 24 (70.6) | 10 (29.4) | 27 (79.4) | 7 (20.6) | ||||
Age (years) | ||||||||||||
16–25 | 43 (18.5) | 189 (81.5) | <0.001 | 163 (70.3) | 69 (29.7) | 0.035 | 180 (77.6) | 52 (22.4) | 0.167 | 222 (95.7) | 10 (4.3) | <0.001 |
26–35 | 38 (17.3) | 182 (82.7) | 138 (62.7) | 82 (37.3) | 172 (78.2) | 48 (21.8) | 196 (89.1) | 24 (10.9) | ||||
36–45 | 36 (29.0) | 88 (71.0) | 70 (56.5) | 54 (43.5) | 90 (72.6) | 34 (27.4) | 88 (71.0) | 36 (29.0) | ||||
45+ | 25 (40.3) | 37 (59.7) | 35 (56.5) | 27 (43.5) | 54 (87.1) | 8 (12.9) | 42 (67.7) | 20 (32.3) | ||||
Area of residence | ||||||||||||
Elsewhere | 46 (31.7) | 99 (68.3) | 0.001 | 91 (62.8) | 54 (37.2) | 0.763 | 121 (83.4) | 24 (16.6) | 0.072 | 126 (86.9) | 19 (13.1) | 0.617 |
Glasgow/Edinburgh | 90 (19.0) | 384 (81.0) | 304 (64.1) | 170 (35.9) | 362 (76.4) | 112 (23.6) | 404 (85.2) | 70 (14.8) | ||||
Employment | ||||||||||||
Employed | 114 (22.2) | 399 (77.8) | 1.00 | 319 (62.2) | 194 (37.8) | 0.109 | 404 (78.8) | 109 (21.2) | 0.232 | 437 (85.2) | 76 (14.8) | 0.284 |
Other | 28 (22.2) | 98 (77.8) | 88 (69.8) | 38 (30.2) | 93 (73.8) | 33 (26.2) | 112 (88.9) | 14 (11.1) | ||||
Education | ||||||||||||
Secondary | 20 (21.1) | 75 (78.9) | 0.860 | 65 (68.4) | 30 (31.6) | 0.561 | 72 (75.8) | 23 (24.2) | 0.837 | 81 (85.3) | 14 (14.7) | 0.262 |
Further/vocational | 48 (20.8) | 183 (79.2) | 147 (63.6) | 84 (36.4) | 182 (78.8) | 49 (21.2) | 206 (89.2) | 25 (10.8) | ||||
Degree/postgraduate | 62 (22.7) | 211 (77.3) | 170 (62.3) | 103 (37.7) | 212 (77.7) | 61 (22.3) | 230 (84.2) | 43 (15.8) | ||||
Frequency of gay scene use | ||||||||||||
Once a month or less | 56 (32.6) | 116 (67.4) | <0.001 | 117 (68.0) | 55 (32.0) | 0.299 | 143 (83.1) | 29 (16.9) | 0.071 | 140 (81.4) | 32 (18.6) | 0.084 |
2–3 times a month | 34 (21.7) | 123 (78.3) | 94 (59.9) | 63 (40.1) | 124 (79.0) | 33 (21.0) | 141 (89.8) | 16 (10.2) | ||||
Once or more a week | 52 (16.8) | 258 (83.2) | 196 (63.2) | 114 (36.8) | 230 (74.2) | 80 (25.8) | 268 (86.5) | 42 (13.5) | ||||
HIV treatment optimism 1* | ||||||||||||
Agree | 32 (25.0) | 96 (75.0) | 0.409 | 80 (62.5) | 48 (37.5) | 0.827 | 95 (74.2) | 33 (25.8) | 0.287 | 103 (80.5) | 25 (19.5) | 0.045 |
Uncertain/disagree | 106 (21.6) | 385 (78.4) | 312 (63.5) | 179 (36.5) | 386 (78.6) | 105 (21.4) | 429 (87.4) | 62 (12.6) | ||||
HIV treatment optimism 2* | ||||||||||||
Agree | 21 (25.3) | 62 (74.7) | 0.479 | 53 (63.9) | 30 (36.1) | 0.915 | 58 (69.9) | 25 (30.1) | 0.066 | 65 (78.3) | 18 (21.7) | 0.032 |
Uncertain/disagree | 117 (21.8) | 419 (78.2) | 339 (63.2) | 197 (36.8) | 423 (78.9) | 113 (21.1) | 467 (87.1) | 69 (12.9) | ||||
Had either an HIV or STI test in previous 12 months | ||||||||||||
No | 56 (24.1) | 176 (75.9) | 0.354 | 150 (64.7) | 82 (35.3) | 0.749 | 189 (81.5) | 43 (18.5) | 0.083 | 204 (87.9) | 28 (12.1) | 0.322 |
Yes | 83 (21.0) | 313 (79.0) | 251 (63.4) | 145 (36.6) | 299 (75.5) | 97 (24.5) | 337 (85.1) | 59 (14.9) | ||||
HIV status (from saliva test) | ||||||||||||
HIV− | 116 (22.1) | 408 (77.9) | 0.945 | 342 (65.3) | 182 (34.7) | 0.049 | 420 (80.2) | 104 (19.8) | <0.001 | 461 (88.0) | 63 (12.0) | <0.001 |
HIV+ | 6 (25.0) | 18 (75.0) | 10 (41.7) | 14 (58.3) | 11 (45.8) | 13 (54.2) | 12 (50.0) | 12 (50.0) | ||||
Did not provide oral fluid specimen | 20 (22.0) | 71 (78.0) | 55 (60.4) | 36 (39.6) | 66 (72.5) | 25 (27.5) | 76 (83.5) | 15 (16.5) |
*HIV treatment optimism 1—‘I am less worried about HIV infection now that treatments have improved’, HIV treatment optimism 2—‘I believe that new drug therapies make people with HIV less infectious’.